Suppr超能文献

用于卵泡刺激素口服靶向递药的工程化纳米载体系统:开发、表征、以及体外和体内性能及靶向性评估。

Engineered Nano-carrier systems for the oral targeted delivery of follicle stimulating Hormone: Development, characterization, and, assessment of in vitro and in vivo performance and targetability.

机构信息

Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka State, India.

Division of Plastic and Reconstructive Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan 114.

出版信息

Int J Pharm. 2023 Apr 25;637:122868. doi: 10.1016/j.ijpharm.2023.122868. Epub 2023 Mar 22.

Abstract

Follicle stimulating hormone (FSH) is widely used for the treatment of female infertility, where the level of FSH is suboptimal due to which arrest in follicular development and anovulation takes place. Currently, only parenteral formulations are available for FSH in the market. Due to the drawbacks of parenteral administration and the high market shares of FSH, there is a need for easily accessible oral formulation. Therefore, enteric coated capsules filled with FSH loaded nanostructured lipid carriers (NLCs) or liposomes were prepared. Preliminary studies such as circular dichroism, SDS-PAGE, FTIR and ELISA were conducted to analyze FSH. Prepared formulations were optimized with respect to the size, polydispersity index, zeta potential, and entrapment efficiency using the design of experiments. Optimized formulations were subjected to particle counts and distribution analysis, TEM analysis, in vitro drug release, dissolution of enteric coated capsules, cell line studies, everted sac rat's intestinal uptake study, pharmacokinetics, pharmacodynamics, and stability studies. In the case of liposomes, RGD conjugation was done by carbodiimide chemistry and conjugation was confirmed by FTIR, HNMR and Raman spectroscopy. The prepared formulations were discrete and spherical. The release of FSH from enteric coated capsules was slow and sustained. The increased permeability of nano-formulations was observed in Caco-2 monoculture as well as in Caco-2 and Raji-B co-culture models. NLCs and liposomes showed an improvement in oral bioavailability and efficacy of FSH in rats. This may be due to mainly chylomicron-assisted lymphatic uptake of NLCs; whereas, in the case of liposomes, RGD-based targeting of β1 integrins of M cells on Peyer's patches may be the main reason for the better effect by FSH. FSH was found to be stable chemically and conformationally. Overall, the study reveals the successful development and evaluation of FSH loaded NLCs and liposomes.

摘要

卵泡刺激素(FSH)被广泛用于治疗女性不孕,由于 FSH 水平不理想,导致卵泡发育停滞和排卵障碍。目前,市场上只有 FSH 的注射制剂。由于注射给药的缺点和 FSH 的高市场份额,因此需要一种易于获得的口服制剂。因此,制备了包封 FSH 的纳米结构脂质载体(NLC)或脂质体肠溶胶囊。进行了初步研究,如圆二色性、SDS-PAGE、FTIR 和 ELISA 分析 FSH。使用实验设计优化了制剂的粒径、多分散指数、Zeta 电位和包封效率。优化后的制剂进行了粒子计数和分布分析、TEM 分析、体外药物释放、肠溶胶囊溶解、细胞系研究、外翻肠囊大鼠肠吸收研究、药代动力学、药效学和稳定性研究。对于脂质体,通过碳二亚胺化学进行了 RGD 缀合,通过 FTIR、HNMR 和拉曼光谱证实了缀合。制备的制剂呈离散状和球形。肠溶胶囊中 FSH 的释放缓慢且持续。纳米制剂在 Caco-2 单培养以及 Caco-2 和 Raji-B 共培养模型中观察到通透性增加。NLC 和脂质体在大鼠中提高了 FSH 的口服生物利用度和疗效。这可能主要是由于 NLC 的乳糜微粒辅助淋巴摄取;而对于脂质体,可能是由于 RGD 靶向 Peyer's 斑上 M 细胞的β1 整合素,是 FSH 更好效果的主要原因。FSH 在化学和构象上均稳定。总的来说,该研究揭示了 FSH 负载的 NLC 和脂质体的成功开发和评价。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验